Compare

Definium Therapeutics, Inc. vs USANA Health Sciences Inc vs Cronos Group Inc. vs Natural Alternatives International Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearDefinium Therapeutics, Inc.
DFTX
USANA Health Sciences Inc
USNA
Cronos Group Inc.
CRON
Natural Alternatives International Inc
NAII
Year ended2025-12-312026-01-032025-12-312026-06-30
Revenuen/a$925.26M$146.59M$142.51M
Revenue growth (YoY)n/a+8.3%+24.6%+9.7%
Gross marginn/a78.3%42.8%6.3%
Operating marginn/a4.0%-11.9%-13.2%
Net marginn/a1.2%-6.4%-14.5%
Net income-$183.79M$10.76M-$9.45M-$20.70M
EPS (Diluted)-$2.06$0.58-$0.02-$3.43
Operating cash flow-$131.56M$22.35M$25.87M-$8.92M
Free cash flown/a$8.53M$149.0K-$12.62M
Cash & equivalents$257.84M$158.38M$791.79M$7.39M
Total assets$440.10M$742.91M$1.20B$126.45M
Total liabilities$107.77M$156.64M$54.18M$76.49M
Shareholders' equity$332.33M$533.10M$1.14B$49.96M
Return on year-end equity-55.3%2.0%-0.8%-41.4%
Shares outstanding98.78M18.28M381.59M6.27M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearDefinium Therapeutics, Inc.USANA Health Sciences IncCronos Group Inc.Natural Alternatives International Inc
Latestn/a$925.26M
Ended 2026-01-03
$146.59M
Ended 2025-12-31
$142.51M
Ended 2026-06-30
1 year earliern/a$854.50M
Ended 2024-12-28
$117.61M
Ended 2024-12-31
$129.86M
Ended 2025-06-30
2 years earliern/a$921.01M
Ended 2023-12-30
$87.24M
Ended 2023-12-31
$113.80M
Ended 2024-06-30
3 years earliern/a$998.60M
Ended 2022-12-31
$86.75M
Ended 2022-12-31
$154.01M
Ended 2023-06-30
4 years earliern/a$1.19B
Ended 2022-01-01
$64.56M
Ended 2021-12-31
$170.97M
Ended 2022-06-30